Literature DB >> 361492

K-cell-mediated antibody-dependent cellular cytotoxicity in chronic active liver disease.

H Kawanishi, R P MacDermott.   

Abstract

These studies were designed to determine the ability of antihepatocyte antibodies from patients with chronic active liver disease to induce killing of rabbit hepatocytes by normal lymphocytes. Normal subjects and patients with chronic persistent hepatitis or chronic active liver disease served as sources of sera, and normal human peripheral lymphocytes and their subsets (T-enriched, K-enriched, and B) served as effectors. Only sera from patients with chronic active liver disease possessed membrane-reactive IgG directed against the surface of rabbit or human hepatocytes. After pretreatment of rabbit hepatocytes with sera from patients with chronic active liver disease, marked cytotoxicity mediated by normal lymphocytes was observed. K-enriched cells mediated the antibody-dependent cellular cytotoxicity, whereas T-enriched cells and B-cells did not. Heat-aggregated human IgG blocked the antibody-dependent cellular cytotoxicity. These data suggest that sera from patients with chronic active liver disease contain IgG antihepatocyte antibodies, which are capable of inducing normal K-cells to kill rabbit hepatocytes in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 361492

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin.

Authors:  T Wada; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-06

Review 2.  The role of liver membrane antigens as targets in autoimmune type liver disease.

Authors:  K H Meyer zum Büschenfelde; T H Hütteroth; M Manns; B Möller
Journal:  Springer Semin Immunopathol       Date:  1980-12

3.  Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity.

Authors:  M Manns; K H Meyer zum Büschenfelde; G Hess
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

4.  Study of cellular immunity in experimental autoimmune hepatitis in mice.

Authors:  Y Mori; T Mori; H Yoshida; S Ueda; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Detection of antibodies to Chang liver cell in sera from patients with chronic liver diseases by 125I-labelled protein A binding assay and the effect of prednisolone and 6-mercaptopurine treatment on the level of the antibodies.

Authors:  Y Inagaki; T Morizane; S Matsumura; N Kawamura; T Watanabe; N Kumagai; T Nakamura; K Tsuchimoto; M Tsuchiya
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

6.  Study of cellular immunity in experimental autoimmune hepatitis in mice: transfer of spleen cells sensitized with liver proteins.

Authors:  Y Mori; T Mori; S Ueda; H Yoshida; K Iesato; Y Wakashin; M Wakashin; K Okuda
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

7.  Antibody dependent cellular cytotoxicity in chronic active liver diseases.

Authors:  S Kakumu; R Hotta; J Kuriki
Journal:  Gastroenterol Jpn       Date:  1981

8.  Antibody dependent cytotoxicity in chronic active liver disease.

Authors:  T Banciu; P Arcan
Journal:  Gastroenterol Jpn       Date:  1988-12

9.  Histological and immunological investigation of liver-specific protein (LSP) immunized rabbits compared with patients with liver disease.

Authors:  C Feighery; G S McDonald; J F Greally; D G Weir
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Antibody to liver-specific lipoprotein in acute and chronic liver diseases. Its quantitative assay with monoclonal antibody, but without the use of liver-specific lipoprotein.

Authors:  S Kakumu; K Yoshioka; A Tsubouchi
Journal:  Gastroenterol Jpn       Date:  1985-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.